Physicochemical Characterization and Phase I Study of CMAB008, an Infliximab Biosimilar Produced by a Different Expression System

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s170913
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PF-06438179/GP1111: An Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2018English

Physicochemical and Functional Characterization of a Biosimilar Adalimumab ZRC-3197

Biosimilars
2014English

Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2019English

Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice

International Journal of Rheumatic Diseases
Rheumatology
2019English

Purification and Physicochemical Characterization of a Human Cytotoxic Factor Produced by a Human Haemic Cell Line

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1981English

A Phase I Dose-Escalation Study of a Biosimilar Trastuzumab in Chinese Metastasis Breast Cancer Patients

SpringerPlus
Multidisciplinary
2015English

Alkylcyanoacrylate Drug Carriers: I. Physicochemical Characterization of Nanoparticles With Different Alkyl Chain Length

International Journal of Pharmaceutics
Pharmaceutical Science
1992English

Characterization of an Exopolymeric Flocculant Produced by a Brachybacterium Sp.

Materials
Materials ScienceCondensed Matter Physics
2013English

Physicochemical Characterization of Coal Tar Produced by Pyrolysis of Coal From Garin Maiganga and Shankodi Deposits

Journal of Minerals and Materials Characterization and Engineering
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy